[Reimbursement for alternative medical treatment in the Netherlands, incomprehensible]. / Vergoeding van alternatieve geneeswijzen in Nederland: onbegrijpelijk.
Ned Tijdschr Geneeskd
; 156(6): A4227, 2012.
Article
en Nl
| MEDLINE
| ID: mdl-22316681
ABSTRACT
It is remarkable that, at a time when not only doctors but also the Health Care Inspectorate (IGZ) and the health insurance companies are paying increasing attention to the quality of conventional medicine, many alternative methods of treatments without a scientific basis are accepted in the Netherlands. Even though it has been conclusively demonstrated that most alternative therapies do not work and despite the absence of scientific proof of the safety and efficacy of alternative treatments, health insurance companies do often reimburse the incurred costs. Because the safety of alternative therapies is not guaranteed, these are neither in the interest of the patient nor of society. Moreover, they are associated with considerable costs for the individual patient. By reimbursing the costs of insufficiently proven treatments, the health insurance companies are applying double standards. Reimbursement for these therapies is made at the expense of other effective and proven treatments. This can be changed through the concerted efforts of policy-makers, doctors, the IGZ, and health insurance companies.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Terapias Complementarias
/
Costos de la Atención en Salud
/
Medicina Basada en la Evidencia
/
Reembolso de Seguro de Salud
Tipo de estudio:
Guideline
Límite:
Humans
País/Región como asunto:
Europa
Idioma:
Nl
Revista:
Ned Tijdschr Geneeskd
Año:
2012
Tipo del documento:
Article
País de afiliación:
Países Bajos